识别灵活多不和脂肪酸的生物活性构造,用于基于干的药物设计
Luying Chen1,2, Mian Wu2, Tomohiko Ohwada2,3
1School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China.
Chemical & pharmaceutical bulletin
|October 26, 2025
概括
研究人员开发了一种新方法来识别体内活跃的多不和脂肪酸 (PUFA) 的特定形状或构造. 这一发现有助于设计模仿这些关键PUFA形状的药物.
科学领域:
- 生物化学 生物化学
- 计算化学计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多不和脂肪酸 (PUFA) 是具有多种生物活动的重要信号分子.
- PUFA的形状灵活性使生物活性形式的识别变得复杂,阻碍了合理的药物设计.
- 了解PUFA形状对于开发向治疗来说至关重要.
研究的目的:
- 建立一种计算方法来描述PUFA的结构相似性.
- 探索PUFAs的构造格局,并确定与蛋白质结合相关的生物活性构造.
- 为设计基于PUFA结构的新型治疗剂提供框架.
主要方法:
- 组合复制品交换分子动力学 (REMD) 模拟与3D WHIM (权重整体不变分子) 描述器.
- 分析了六种不同的PUFA的结构空间.
- 合成调节剂与已识别的PUFA生物活性构成的比较动力学.
主要成果:
- 确定了在蛋白质结合上填充的PUFA适合物的特定集群,称为生物活性适合物.
- 证明合成调节剂可以作为这些生物活性PUFA构成的刚性模仿剂.
- 验证了一种新的计算方法来表征形状相似性.
结论:
- 开发的方法有效地描述了PUFA的构造相似性,并确定了生物活性构造.
- 合成化合物可以合理地设计为PUFA生物活性构成的刚性模仿物.
- 这种方法为开发针对PUFA介导途径的新药提供了有前途的战略.
相关概念视频
Conserved Binding Sites
5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
Ligand Binding Sites
14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Ligand Binding Sites
8.6K
8.6K
Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
The Equilibrium Binding Constant and Binding Strength
14.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.8K


